Wealth & Finance April 2017

29 April 2017 “Due to their unprecedented resolution per¬- formance, we are convinced there is also a bright future for μPAC® micro-Chip columns to be used in combination with simplified, lower cost Mass Spectrometry systems, introducing an affordable alternative in many more settings and places. Ultimately, we envision the added value of the μPAC® micro-Chip columns also augmented by integrating micro-electronic functionalities on the very same silicon wafer substrate.” “The business perspectives are very appealing. The market for analytical liquid chromatography columns is estimated to be over $1.5 billion, with double-digit growth driven by the progress in systems biology research, biomarker discovery research and biopharmaceuticals development. Now it’s up to PharmaFluidics to claim its share of the field, with an exciting new technology!” Reference *DiMasi, J.A., Grabowski, H.G., & Hansen, R.W. (2016). Innovation in the pharma- ceu¬tical industry: New estimates of R&D costs. Journal of Health Economics, 47, 20−33. Company: PharmaFluidics Name: Johan Devenyns, Managing Director; Paul Jacobs - Co-founder – COO Email: [email protected] Web Address: www.pharmafluidics.com Address: Technologiepark-Zwijnaarde 3 B-9052 Gent Belgium Telephone: +32 9 241 56 57